Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06784531

The Influence of Race and MitoQ Supplementation on Skin Blood Flow in the Cold

The Influence of Race and MitoQ Supplementation on Skin Perfusion in the Cold

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
United States Army Research Institute of Environmental Medicine · Federal
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Individuals who operate in cold weather are at risk of developing cold injuries, for example, frostbite. They also often experience a loss of hand function and joint mobility due to a decrease in skin temperature and blood flow. In addition, the risk of getting a cold injury is higher in the Black population compared to other racial and ethnic groups. Increases in oxidant compounds can cause the blood vessels in the skin to narrow and decrease skin temperature in the cold. However, it is unknown whether the higher risk of cold injury in Black individuals is because of a greater amount of oxidant compounds in the blood vessels. The purpose of this research is to see if an antioxidant supplement called MitoQ can help to improve skin temperature and blood flow in the cold and if the improvement is greater in Black individuals.

Detailed description

In a randomized, double-blinded, crossover design, healthy volunteers (18-40 yrs) will undergo a set of cold exposures following acute ingestion of a high-dose MitoQ supplement and placebo. The cold exposures will consist of a hand immersion in 54°F water and a 90-min exposure to 41°F air during which skin blood flow and temperatures will be measured. The hypothesis is that the declines in skin blood flow and temperature will be greater during cold exposure in Black individuals and that MitoQ supplementation will improve skin blood flow and temperature to a greater extent in Black individuals.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMitoquinone mesylate (MitoQ)Four 20 mg MitoQ capsules (80 mg total) are ingested orally.
DIETARY_SUPPLEMENTPlaceboFour placebo (microcrystalline cellulose) capsules are ingested orally.
OTHERCold Water Hand ImmersionVolunteers place one hand in cold (54°F) water for 30 minutes.
OTHERCold Air ExposureVolunteers sit in cold (41°F) air for 90 minutes.

Timeline

Start date
2024-09-16
Primary completion
2025-10-28
Completion
2026-01-01
First posted
2025-01-20
Last updated
2025-12-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06784531. Inclusion in this directory is not an endorsement.

The Influence of Race and MitoQ Supplementation on Skin Blood Flow in the Cold (NCT06784531) · Clinical Trials Directory